Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether a 6-week treatment with 4 g Omacor/day
improves the baseline and postprandial endothelial function (after a high-fat meal) in
patients with type 2 diabetes mellitus.
Phase:
Phase 4
Details
Lead Sponsor:
Ruhr University of Bochum
Collaborators:
Heart and Diabetes Center North-Rhine Westfalia Solvay Pharmaceuticals